New perspectives into the molecular pathogenesis and treatment of type 2 diabetes.
Department of Medicine, Life Sciences Institute, University of Michigan School of Medicine, Ann Arbor, MI 48109, USA.
A R
AR
Saltiel
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology* / Q000235:genetics / Q000378:metabolism* / Q000503:physiopathology / Q000628:therapy*; D006003:Glycogen / Q000096:biosynthesis; D006801:Humans; D007328:Insulin / Q000378:metabolism; D007333:Insulin Resistance; D007515:Islets of Langerhans / Q000378:metabolism; D008954:Models, Biological; D009765:Obesity; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D011972:Receptor, Insulin / Q000378:metabolism; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism; D015398:Signal Transduction; D014157:Transcription Factors / Q000378:metabolism
D001786:Blood Glucose; D007328:Insulin; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors; D006003:Glycogen; D011505:Protein-Tyrosine Kinases; D011972:Receptor, Insulin